首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1878103

腦脊髓液（CSF）管理市場－2025-2030年預測

Cerebrospinal Fluid (CSF) Management Market - Forecasts from 2025 to 2030

出版日期: 2025年10月20日 | 出版商:

Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球腦脊髓液 (CSF) 管理市場預計將從 2025 年的 858,859,000 美元成長到 2030 年的 1,076,454,000 美元，複合年成長率為 4.62%。

腦脊髓液（CSF）是存在於大腦和脊髓中的重要液體，提供必要的機械和免疫保護。對腦脊髓液進行有效管理對於治療腦脊髓液異常積聚引起的疾病至關重要。腦脊髓液管理裝置，包括引流系統和分流器，旨在控制和引導腦脊髓液從腦室流出，從而預防水腦症等併發症。由於全球醫療保健趨勢的協同作用，這些裝置的市場正在顯著擴張。

推動市場成長的關鍵因素包括新興經濟體神經專科醫院的建立以及旨在提供更具成本效益的治療方案的持續投資。此外，全球神經系統疾病盛行率的不斷上升也是一個潛在的驅動力。同時，人口老化加劇、開發中國家可支配收入的增加以及醫療基礎設施的不斷進步，也推動了微創手術的高需求和日益成長的趨勢。用於治療各種神經血管疾病的新型技術改良產品的推出，也為市場創造了盈利的成長前景。

然而，市場擴張也面臨許多限制因素。其中一項主要挑戰是全球合格神經外科醫生短缺，鑑於老年人口快速成長，對高品質神經系統護理的需求日益增加，這一問題尤其嚴峻。此外，腦脊髓液分流術相關併發症（特別是裝置故障和感測器相關感染疾病）的增加，預計將成為限制市場成長的主要問題。這些專用醫療設備的高成本也進一步阻礙了其廣泛應用，尤其是在對成本較為敏感的市場。

市場區隔分析

依產品類型：

全球腦脊髓液管理市場分為外部引流系統和分流器兩大類。預計分流器市場將主導整個產業。這一主導地位歸因於全球分流手術數量的不斷成長，以及因裝置故障和感染疾病導致的翻修手術數量的相應增加。現代分流系統在降低翻修手術率和縮短平均住院時間的優勢，是推動此細分市場擴張的主要因素。

按最終用戶分類：

市場分為成人、兒童和老年三個細分市場。兒童市場預計將佔據相當大的市場佔有率，這主要是由於先天性水腦症在兒童群體中的發病率不斷上升，以及為治療該疾病及相關疾病而對兒童進行的大量分流手術所致。

按行業分類：

按醫院、診所和其他機構進行分析，預計醫院部門將佔據相當大的市場佔有率，並以最快的速度擴張，因為大量複雜的腦脊髓液管理病例，尤其是在老年人群體中，都是在醫院環境中治療的，而醫院集中了所需的外科專業知識和基礎設施。

區域市場展望

市場按地理區域分類包括北美、南美、歐洲、中東和非洲以及亞太地區。

亞太地區預計將實現最高成長率。這項加速成長主要得益於蓬勃發展的醫療旅遊業、先天性腦水腦症盛行率的上升以及各國人口老化加劇。此外，持續進行的研究合作以及政府主導的旨在提升神經系統疾病治療水平的投資，也是推動該地區市場擴張的關鍵因素。

北美市場預計也將顯著成長，這主要得益於研究機構為推動神經系統疾病治療所採取的策略性舉措。健全的法規結構有利於新型治療方法的核准，加上全球主要市場參與者的穩固地位，為區域市場的擴張提供了強而有力的支撐。該地區領先醫療設備公司的集中佈局，確保了創新和商業活動的持續發展。

主要市場趨勢

腦脊髓液管理領域正經歷快速變革，其驅動力來自於旨在提升診斷和治療能力的策略聯盟和監管發展。近期趨勢凸顯了製藥和醫療設備公司攜手合作，開發將治療藥物直接輸送至腦脊髓液的一體化解決方案。此外，新診斷測試的監管核准也提升了我們識別和測量阿茲海默症神經系統疾病病理過程的能力，從而提高了診斷準確性並有助於監測治療進展。這些舉措體現了業界致力於透過夥伴關係和技術整合實現創新，從而更好地支持患有嚴重神經系統疾病的患者。

本報告的主要優勢：

深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
市場促進因素與未來趨勢：探索市場促進因素和關鍵趨勢及其對未來市場發展的影響。
可操作的建議：利用這些見解，在快速變化的環境中製定策略決策，發展新的商業機會和收入來源。
受眾廣泛：對Start-Ups、研究機構、顧問公司、中小企業和大型企業都很有用且經濟實惠。

企業使用我們的報告做什麼？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

2022年至2024年的歷史數據和2025年至2030年的預測數據
成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
競爭定位、策略和市場佔有率分析
按業務板塊和地區分類的收入成長和預測評估，包括國家/地區
公司概況（策略、產品、財務資訊、關鍵發展等）

全球腦脊髓液（CSF）管理市場細分及分析如下：

腦脊髓液 (CSF) 市場按產品類型分類
腦脊髓液分流術
外部排水系統
腦脊髓液（CSF）市場按最終用戶分類
兒童
成人
老年人
腦脊髓液 (CSF) 市場按行業分類
醫院
診所
其他
腦脊髓液 (CSF) 市場（按地區分類）
北美洲
美國
加拿大
墨西哥
南美洲
巴西
阿根廷
其他
歐洲
德國
法國
英國
西班牙
其他
中東和非洲
沙烏地阿拉伯
阿拉伯聯合大公國
其他
亞太地區
中國
印度
日本
韓國
印尼
泰國
其他

Medtronic
Integra LifeSciences
Johnson & Johnson MEDTECH
B. Braun Melsungen AG
Spiegelberg GmbH & Co. KG（Acquired by SHS Medizintechnik Holding GmbH）
Sophysa（A subsidiary of tkb group）
Natus Medical Incorporated（Acquired by ArchiMed Group）
Argi Grup
Moller Medical GMBH
Delta Surgical
Wellong Instruments Co., Ltd.

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要收益
調查方法
簡稱

簡介目錄

Product Code: KSI061611877

The global cerebrospinal fluid (CSF) management market, with a 4.62% CAGR, is expected to grow to USD 1,076.454 million by 2030 from USD 858.859 million in 2025.

Cerebrospinal fluid (CSF) is a vital bodily fluid found in the brain and spinal cord, providing essential mechanical and immunological protection. The management of this fluid is critical in treating conditions involving its improper accumulation. CSF management devices, which include drainage systems and shunts, are designed to control and divert the flow of CSF away from the brain's ventricles, thereby preventing complications such as hydrocephalus. The market for these devices is experiencing significant expansion, driven by a confluence of global healthcare trends.

Key factors propelling market growth include the development of specialized neuro-hospitals in emerging economies and ongoing investments aimed at delivering more cost-effective treatments. Furthermore, the growing global prevalence of neurological disorders is a fundamental driver. This is compounded by a high and increasing demand for minimally invasive surgical procedures, a trend fueled by a growing geriatric population, rising disposable incomes in developing nations, and continuous advancements in healthcare infrastructure. The introduction of new, technologically improved products for treating various neurovascular illnesses is also creating lucrative growth prospects for the market.

However, the market's expansion faces significant constraints. A primary challenge is the global scarcity of qualified neurosurgeons, a workforce shortage that is particularly acute given the rapidly increasing senior population requiring quality neurological care. Additionally, rising complications associated with CSF shunts, including device malfunctions and sensor-related infections, are major issues predicted to limit growth. The high cost of these specialized medical devices further hampers widespread adoption, especially in cost-sensitive markets.

Market Segment Analysis

By Product Type:

The global cerebrospinal fluid management market is segmented into external drainage systems and shunts. The shunts segment is expected to dominate the industry. This dominance is attributable to the rising number of shunting procedures performed worldwide and a corresponding increase in revision shunt surgeries necessitated by device malfunction or infection. The advantages of modern shunt systems, which offer a reduced likelihood of revision surgery and shorter average hospital stays, are key factors fueling this segment's expansion.

By End-Users:

The market is divided into adult, pediatric, and geriatric segments. The pediatric category is estimated to account for a considerable market share. This is fuelled by the increased prevalence of congenital hydrocephalus in the pediatric population and a high volume of shunting procedures performed on children to manage this and other related conditions.

By Industry:

Analyzed across hospitals, clinics, and other settings, the hospital segment is anticipated to hold a sizable market share and expand at the quickest rate. This is due to the large number of complex CSF management cases, particularly within the aging population, being treated in hospital environments where the necessary surgical expertise and infrastructure are concentrated.

Geographical Market Outlook

A geographical segmentation of the market includes North America, South America, Europe, the Middle East and Africa, and the Asia Pacific.

The Asia Pacific region is expected to grow at the highest rate. This accelerated growth is driven by developing medical tourism, a rising prevalence of congenital hydrocephalus, and a growing geriatric population in various nations. Furthermore, ongoing research collaborations and government-backed investments aimed at bolstering treatment for neurological disorders are significant drivers of regional market expansion.

North America is also expected to see considerable growth, fueled by strategic efforts undertaken by research institutes to advance the treatment of neurological conditions. The presence of a robust regulatory framework that facilitates the approval of new treatments, coupled with the well-established presence of major global market players, acts as a powerful catalyst for regional market expansion. The concentration of leading medical device companies in this region ensures a steady pipeline of innovation and commercial activity.

Key Market Developments

The cerebrospinal fluid management landscape is dynamic, characterized by strategic partnerships and regulatory advancements aimed at improving diagnostic and therapeutic capabilities. Recent developments highlight a trend towards collaboration between pharmaceutical and device companies to create integrated solutions for delivering therapies directly to the CSF. Furthermore, regulatory clearances for new diagnostic assays are enhancing the ability to define and measure pathological processes in neurological diseases like Alzheimer's, thereby improving diagnosis and treatment monitoring. These activities reflect an industry focused on innovation through partnership and technological convergence to better serve patients with severe neurological conditions.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The Global Cerebrospinal Fluid (CSF) Management market is segmented and analyzed as follows:

CEREBROSPINAL FLUID (CSF) MARKET BY PRODUCT TYPE
CSF Shunts
External Drainage System
CEREBROSPINAL FLUID (CSF) MARKET BY END-USER
Pediatric
Adult
Geriatric
CEREBROSPINAL FLUID (CSF) MARKET BY INDUSTRY
Hospital
Clinics
Others
CEREBROSPINAL FLUID (CSF) MARKET BY GEOGRAPHY
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CEREBROSPINAL FLUID (CSF) MARKET BY PRODUCT TYPE

5.1. Introduction
5.2. CSF Shunts
5.3. External Drainage System

6. CEREBROSPINAL FLUID (CSF) MARKET BY END-USER

6.1. Introduction
6.2. Pediatric
6.3. Adult
6.4. Geriatric

7. CEREBROSPINAL FLUID (CSF) MARKET BY INDUSTRY

7.1. Introduction
7.2. Hospital
7.3. Clinics
7.4. Others

8. CEREBROSPINAL FLUID (CSF) MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others